Work

Data from Epigenetic Markers in Rectal Cancer

Year: 2023

Type: other

Abstract: DNA methylation changes in rectal cancer may serve as a new screening marker and a tool for monitoring recurrence. Importantly, these changes may also function as a predictive marker to allow appropriate exclusion of (neo)adjuvant therapies in patients at low risk for disease recurrence, sparing them from potential treatment-related morbidities. Clin Cancer Res; 16(10); 2699–701. ©2010 AACR.

DOI: 10.1158/1078-0432.c.6519326

Authors: Lei Xu, Brian G. Czito, Christopher G. Willett

Institutions: Massachusetts General Hospital, Duke Medical Center

Language: English

Topic: Epigenetics and DNA Methylation

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4361943826

Cites: 9

Cited by:

Related to: 10